Cargando…

Non-invasive assessment of NAFLD as systemic disease—A machine learning perspective

BACKGROUND & AIMS: Current non-invasive scores for the assessment of severity of non-alcoholic fatty liver disease (NAFLD) and identification of patients with non-alcoholic steatohepatitis (NASH) have insufficient performance to be included in clinical routine. In the current study, we developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canbay, Ali, Kälsch, Julia, Neumann, Ursula, Rau, Monika, Hohenester, Simon, Baba, Hideo A., Rust, Christian, Geier, Andreas, Heider, Dominik, Sowa, Jan-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435145/ https://www.ncbi.nlm.nih.gov/pubmed/30913263 http://dx.doi.org/10.1371/journal.pone.0214436

Ejemplares similares

Compensation of feature selection biases accompanied with improved predictive performance for binary classification by using a novel ensemble feature selection approach
por: Neumann, Ursula, et al.
Publicado: (2016)

Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD
por: Sowa, Jan-Peter, et al.
Publicado: (2013)

Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
por: Baars, Theodor, et al.
Publicado: (2018)

Characterization of two types of intranuclear hepatocellular inclusions in NAFLD
por: Schwertheim, Suzan, et al.
Publicado: (2020)

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients
por: Kälsch, Julia, et al.
Publicado: (2011)

In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter
por: Baars, Theodor, et al.
Publicado: (2016)

Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort
por: Kälsch, Julia, et al.
Publicado: (2015)

Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels
por: Schwertheim, Suzan, et al.
Publicado: (2023)

Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4
por: John, Katharina, et al.
Publicado: (2022)

Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD
por: Leven, Anna-Sophia, et al.
Publicado: (2021)

Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
por: Liebig, Stephanie, et al.
Publicado: (2019)

NIKEI: A New Inexpensive and Non-Invasive Scoring System to Exclude Advanced Fibrosis in Patients with NAFLD
por: Demir, Münevver, et al.
Publicado: (2013)

Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients
por: Bischoff, Monika, et al.
Publicado: (2022)

Intersektorales Management von Patienten mit unklarer Leberwerterhöhung und nichtalkoholischer Fettlebererkrankung (NAFLD)
por: Teufel, Andreas, et al.
Publicado: (2023)

Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
por: Sowa, Jan-Peter, et al.
Publicado: (2014)

EFS: an ensemble feature selection tool implemented as R-package and web-application
por: Neumann, Ursula, et al.
Publicado: (2017)

A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease
por: Lambrecht, Joeri, et al.
Publicado: (2019)

Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
por: Gottlieb, Aline, et al.
Publicado: (2019)

Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure
por: Manka, Paul, et al.
Publicado: (2013)

Host Genetic Variants in the Pathogenesis of Hepatitis C
por: Rau, Monika, et al.
Publicado: (2012)

Spleen Stiffness Differentiates Between Acute and Chronic Liver Damage and Predicts Hepatic Decompensation
por: Meister, Phil, et al.
Publicado: (2019)

Screening for nonalcoholic fatty liver disease-when, who and how?
por: Dietrich, Christoph G, et al.
Publicado: (2021)

Exploiting HIV-1 protease and reverse transcriptase cross-resistance information for improved drug resistance prediction by means of multi-label classification
por: Riemenschneider, Mona, et al.
Publicado: (2016)

Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience
por: Anastasiou, Olympia E, et al.
Publicado: (2016)

ContraDRG: Automatic Partial Charge Prediction by Machine Learning
por: Martin, Roman, et al.
Publicado: (2019)

Machine learning on normalized protein sequences
por: Heider, Dominik, et al.
Publicado: (2011)

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
por: Canbay, Ali, et al.
Publicado: (2019)

Machine learning with asymmetric abstention for biomedical decision-making
por: Gandouz, Mariem, et al.
Publicado: (2021)

Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury
por: Sydor, Svenja, et al.
Publicado: (2017)

Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis
por: Sydor, Svenja, et al.
Publicado: (2017)

Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD
por: Pantano, Lorena, et al.
Publicado: (2021)

Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients
por: Buechter, Matthias, et al.
Publicado: (2018)

Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
por: Hu, Haiming, et al.
Publicado: (2019)

Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management
por: Lonardo, Amedeo, et al.
Publicado: (2021)

Liraglutide + PYY(3-36) Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements
por: Metzner, Valentin, et al.
Publicado: (2022)

Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study
por: Vali, Yasaman, et al.
Publicado: (2022)

Human Ex-Vivo Liver Model for Acetaminophen-induced Liver Damage
por: Schreiter, Thomas, et al.
Publicado: (2016)

ODNA: identification of organellar DNA by machine learning
por: Martin, Roman, et al.
Publicado: (2023)

From bedside to bench and back again—molecular mechanisms in acute liver failure
por: Sowa, Jan-Peter, et al.
Publicado: (2014)

Evaluation of NAFLD and fibrosis in obese patients – a comparison of histological and clinical scoring systems
por: Schmitz, Sophia Marie-Therese, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hr6gr9frqninnmsc5dvpgupeii